Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Obstet Gynecol. 2020 Apr;135(4):778–788. doi: 10.1097/AOG.0000000000003754

Figure 2.

Figure 2.

Hepatitis C virus antibody seroprevalence over time regardless of enrollment into the observational study, Maternal–Fetal Medicine Units Network, October 2012–December 2015. Hepatitis C virus antibody positive defined as signal to cut–off value at least 5. Squares indicate percentage; bars indicate 95% CI. Includes 3–month interval data from October 2012 through December 2015.